New drug aims to rev up immune system against tough colon cancer

NCT ID NCT06824064

First seen Jan 08, 2026 · Last updated Apr 30, 2026 · Updated 15 times

Summary

This study tests an experimental drug called RBS2418 in 150 adults with advanced colorectal cancer that has spread and is no longer responding to standard treatments. The drug works by helping the immune system recognize and attack cancer cells. Participants will receive either RBS2418 or a placebo alongside best supportive care, and researchers will track how long they live without the cancer growing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Community Clinical Trials

    RECRUITING

    Kingwood, Texas, 77339, United States

  • Tam Anh TP. Ho Chi Minh General Hospital

    RECRUITING

    Ho Chi Minh City, Ho Chi Minh City, 70000, Vietnam

  • Tam Anh, Ha Noi General Hospital

    RECRUITING

    Hà Nội, 10000, Vietnam

Conditions

Explore the condition pages connected to this study.